Mechanistically, ATO increased ROS production and DNA damage in ESCC and OSCC cells, which led to a transient upregulation and nuclear translocation of Cyclin D1, followed with DNA damage induced proteasomal degradation of Cyclin D1 at later time points. The gene discussed is CCND1; the disease is esophageal squamous cell carcinoma.